HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Ligi Selected Research

glucuronyl glucosamine glycan sulfate (sulodexide)

10/2017Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing.
10/2016Chronic venous disease - Part II: Proteolytic biomarkers in wound healing.
10/2016Chronic venous disease - Part I: Inflammatory biomarkers in wound healing.
5/2013Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Ligi Research Topics

Disease

4Wounds and Injuries (Trauma)
03/2022 - 10/2016
3Infections
03/2022 - 01/2016
3Atherosclerosis
09/2021 - 12/2018
3Inflammation (Inflammations)
12/2020 - 10/2010
3Venous Insufficiency
12/2020 - 10/2017
3Chronic Disease (Chronic Diseases)
11/2020 - 05/2013
3Leg Ulcer
10/2016 - 07/2014
2Thromboangiitis Obliterans (Buerger's Disease)
09/2021 - 04/2020
2Cysts
04/2015 - 06/2014
2Neoplasms (Cancer)
07/2013 - 10/2010
2Breast Neoplasms (Breast Cancer)
07/2013 - 10/2010
1Stroke (Strokes)
03/2022
1Sepsis (Septicemia)
03/2022
1Myocardial Infarction
03/2022
1COVID-19
03/2022
1Vasculitis (Vasculitides)
09/2021
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
09/2021
1Ulcer
12/2020
1Hemoglobinopathies
11/2020
1Diabetes Mellitus
11/2020
1Metabolic Diseases (Metabolic Disease)
11/2020
1Chronic Kidney Failure (Chronic Renal Failure)
11/2020
1Body Weight (Weight, Body)
03/2020
1Type 2 Diabetes Mellitus (MODY)
03/2020
1Hypoglycemia (Reactive Hypoglycemia)
03/2020
1Multiple Sclerosis
01/2018
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2018
1Pain (Aches)
10/2016
1Virus Diseases (Viral Diseases)
01/2016
1Murine Acquired Immunodeficiency Syndrome (MAIDS)
01/2016
1Edema (Dropsy)
01/2016
1Fibrocystic Breast Disease (Chronic Cystic Mastitis)
06/2014
1Breast Cyst
06/2014
1Breast Diseases (Breast Disease)
07/2013
1Vascular Diseases (Vascular Disease)
05/2013
1Leukemia
05/2013
1Varicose Veins (Varicose Vein)
05/2013

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
03/2022 - 07/2013
5Matrix Metalloproteinases (MMPs)IBA
12/2020 - 05/2013
4GlycosaminoglycansIBA
10/2017 - 05/2013
4glucuronyl glucosamine glycan sulfate (sulodexide)IBA
10/2017 - 05/2013
3CytokinesIBA
12/2020 - 01/2014
2AntioxidantsIBA
09/2021 - 04/2020
2oxidized low density lipoproteinIBA
09/2021 - 12/2018
2LipidsIBA
09/2021 - 03/2020
2CollagenIBA
12/2020 - 05/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2020 - 10/2017
2ChemokinesIBA
12/2020 - 01/2014
2AlbuminsIBA
12/2020 - 11/2020
2Glucose (Dextrose)FDA LinkGeneric
11/2020 - 03/2020
2Metalloproteases (Metalloproteinases)IBA
12/2018 - 01/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015 - 01/2014
1Biological ProductsIBA
03/2022
1Histones (Histone)IBA
03/2022
1Troleandomycin (TAO)FDA Link
09/2021
1AutoantibodiesIBA
09/2021
1CreatinineIBA
09/2021
1fibrin fragment D (D-dimer)IBA
09/2021
1Protein CIBA
09/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2021
1Plasminogen Activators (Plasminogen Activator)IBA
12/2020
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2020
1FibrinIBA
12/2020
1Pancreatic Elastase (Elastase)IBA
12/2020
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2020
1Hemoglobins (Hemoglobin)IBA
11/2020
1Dipeptidyl-Peptidase IV InhibitorsIBA
03/2020
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
03/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2020
1Sodium-Glucose Transport ProteinsIBA
03/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
03/2020
1Oligoclonal BandsIBA
01/2018
1EndoglinIBA
10/2017
1Protein Isoforms (Isoforms)IBA
10/2017
1Messenger RNA (mRNA)IBA
01/2016
1Glutathione (Reduced Glutathione)IBA
01/2016
1Interleukin-12 (IL 12)IBA
01/2016
1Protective AgentsIBA
01/2016
1Sulfhydryl Compounds (Thiols)IBA
01/2016
1DisaccharidesIBA
06/2014
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
06/2014
1Plasminogen Activator Inhibitor 1IBA
07/2013
1Tumor Biomarkers (Tumor Markers)IBA
07/2013
1Proteins (Proteins, Gene)FDA Link
07/2013
1EnzymesIBA
05/2013
1GelatinasesIBA
05/2013
1IronIBA
10/2010
1Transferrin (beta 2 Transferrin)IBA
10/2010
1Ferritins (Ferritin)IBA
10/2010
1Iron-Binding ProteinsIBA
10/2010
1Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2010
1C-Reactive ProteinIBA
10/2010

Therapy/Procedure

6Therapeutics
03/2022 - 01/2016
1Operative Surgical Procedures
12/2020
1Immunotherapy
01/2016